Tankersley Michael S, Walker Russell L, Butler William K, Hagan Larry L, Napoli Diane C, Freeman Theodore M
Allergy and Immunology Department, Wilford Hall Medical Center, Lackland Air Force Base, TX, USA.
J Allergy Clin Immunol. 2002 Mar;109(3):556-62. doi: 10.1067/mai.2002.121956.
Hypersensitivity to the sting of the imported fire ant (IFA) is a growing and significant cause of morbidity and mortality in the United States. Conventional immunotherapy with IFA whole body extract (WBE) has been shown to be effective; however, rush immunotherapy (RIT) with IFA WBE has not been studied.
In this study, we evaluated the safety and efficacy of RIT with IFA WBE and sought to determine whether prophylactic pretreatment with antihistamines and steroids reduces the systemic reaction rate associated with RIT.
Patients with IFA hypersensitivity were randomized to placebo or twice-daily terfenadine 60 mg, ranitidine 150 mg, and prednisone 30 mg initiated 2 days before RIT in a double-blinded study. The 2-day RIT protocol consisted of hourly injections to achieve a final dose of 0.3 mL 1:100 wt/vol. Patients returned on day 8 to receive 2 hourly injections of 0.25 mL 1:100 wt/vol (total, 0.5 mL) and again on day 15 for a single injection of 0.5 mL 1:100 wt/vol. Efficacy of the protocol was determined on day 22, a pair of IFA sting challenges being performed 2 hours apart.
Fifty-nine patients were enrolled into the study; a total of 58 patients (age range, 18 to 49 years) initiated the 2-day RIT. Only 3 patients (5.2%) experienced a mild systemic reaction during the protocol. Among those experiencing a systemic reaction with RIT, there was no statistical difference between the 2 premedication groups (3.6% active and 6.7% placebo; P =.87). Sting challenges were performed on 56 patients for a total of 112+ stings; only 1 mild systemic reaction occurred (efficacy, 98.2%).
RIT with IFA WBE for IFA hypersensitivity is both safe and efficacious; the rate of mild systemic reactions is low. Premedication is not necessary, inasmuch as prophylactic pretreatment with antihistamines and steroids did not reduce the systemic reaction rate associated with RIT.
对入侵红火蚁(IFA)叮咬过敏在美国正成为发病率和死亡率不断上升的重要原因。已证明使用IFA全身体液提取物(WBE)进行常规免疫疗法是有效的;然而,尚未对使用IFA WBE进行快速免疫疗法(RIT)进行研究。
在本研究中,我们评估了使用IFA WBE进行RIT的安全性和有效性,并试图确定使用抗组胺药和类固醇进行预防性预处理是否能降低与RIT相关的全身反应率。
在一项双盲研究中,将IFA过敏患者随机分为安慰剂组或在RIT前2天开始每日两次服用60毫克特非那定、150毫克雷尼替丁和30毫克泼尼松。为期2天的RIT方案包括每小时注射一次,最终剂量达到0.3毫升1:100重量/体积。患者在第8天返回接受2次每小时0.25毫升1:100重量/体积的注射(共0.5毫升),并在第15天再次接受一次0.5毫升1:100重量/体积的注射。在第22天确定方案的有效性,相隔2小时进行一对IFA叮咬激发试验。
59名患者纳入研究;共有58名患者(年龄范围18至49岁)开始了为期2天的RIT。在方案期间,只有3名患者(5.2%)出现轻度全身反应。在经历RIT全身反应的患者中,两个预处理组之间无统计学差异(活性组3.6%,安慰剂组6.7%;P = 0.87)。对56名患者进行了叮咬激发试验,共进行了112次以上的叮咬;仅发生1次轻度全身反应(有效性98.2%)。
使用IFA WBE进行RIT治疗IFA过敏既安全又有效;轻度全身反应率较低。由于使用抗组胺药和类固醇进行预防性预处理并未降低与RIT相关的全身反应率,因此无需进行预处理。